JP2019513794A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019513794A5 JP2019513794A5 JP2018554331A JP2018554331A JP2019513794A5 JP 2019513794 A5 JP2019513794 A5 JP 2019513794A5 JP 2018554331 A JP2018554331 A JP 2018554331A JP 2018554331 A JP2018554331 A JP 2018554331A JP 2019513794 A5 JP2019513794 A5 JP 2019513794A5
- Authority
- JP
- Japan
- Prior art keywords
- raav
- suspension
- aqueous suspension
- enhancer
- aav
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007900 aqueous suspension Substances 0.000 claims 7
- 241000702421 Dependoparvovirus Species 0.000 claims 6
- 108010071690 Prealbumin Proteins 0.000 claims 5
- 102000009190 Transthyretin Human genes 0.000 claims 5
- 239000003623 enhancer Substances 0.000 claims 5
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 claims 4
- 102100026735 Coagulation factor VIII Human genes 0.000 claims 3
- 201000003542 Factor VIII deficiency Diseases 0.000 claims 3
- 208000009292 Hemophilia A Diseases 0.000 claims 3
- 210000000234 capsid Anatomy 0.000 claims 3
- 210000004185 liver Anatomy 0.000 claims 3
- 239000000725 suspension Substances 0.000 claims 3
- 108091026890 Coding region Proteins 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 241000702423 Adeno-associated virus - 2 Species 0.000 claims 1
- 230000001112 coagulating effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000003494 hepatotrophic effect Effects 0.000 claims 1
- 102000057593 human F8 Human genes 0.000 claims 1
- 229960000900 human factor viii Drugs 0.000 claims 1
- 238000010253 intravenous injection Methods 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022011052A JP2022062121A (ja) | 2016-04-15 | 2022-01-27 | 血友病ａ治療に対する遺伝子療法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662323336P | 2016-04-15 | 2016-04-15 | |
| US62/323,336 | 2016-04-15 | ||
| US201662331807P | 2016-05-04 | 2016-05-04 | |
| US62/331,807 | 2016-05-04 | ||
| US201662428866P | 2016-12-01 | 2016-12-01 | |
| US62/428,866 | 2016-12-01 | ||
| PCT/US2017/027396 WO2017180857A1 (en) | 2016-04-15 | 2017-04-13 | Gene therapy for treating hemophilia a |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022011052A Division JP2022062121A (ja) | 2016-04-15 | 2022-01-27 | 血友病ａ治療に対する遺伝子療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019513794A JP2019513794A (ja) | 2019-05-30 |
| JP2019513794A5 true JP2019513794A5 (https=) | 2020-05-21 |
| JP7347933B2 JP7347933B2 (ja) | 2023-09-20 |
Family
ID=59253992
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018554331A Active JP7347933B2 (ja) | 2016-04-15 | 2017-04-13 | 血友病ａ治療に対する遺伝子療法 |
| JP2022011052A Pending JP2022062121A (ja) | 2016-04-15 | 2022-01-27 | 血友病ａ治療に対する遺伝子療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022011052A Pending JP2022062121A (ja) | 2016-04-15 | 2022-01-27 | 血友病ａ治療に対する遺伝子療法 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US11779656B2 (https=) |
| EP (1) | EP3452102B9 (https=) |
| JP (2) | JP7347933B2 (https=) |
| KR (1) | KR102450833B1 (https=) |
| CN (1) | CN109562191A (https=) |
| AU (1) | AU2017248659B2 (https=) |
| BR (1) | BR112018071200A2 (https=) |
| CA (1) | CA3019425A1 (https=) |
| IL (1) | IL262215B2 (https=) |
| MX (1) | MX2018012537A (https=) |
| PE (2) | PE20181922A1 (https=) |
| RU (1) | RU2762257C2 (https=) |
| SA (1) | SA518400233B1 (https=) |
| SG (2) | SG10202009849WA (https=) |
| TW (1) | TWI791433B (https=) |
| WO (1) | WO2017180857A1 (https=) |
| ZA (1) | ZA201806477B (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201813067T4 (tr) | 2008-09-15 | 2018-09-21 | Uniqure Biopharma B V | Faktör IX polipeptit mutantı, bunun kullanımları ve bunu üretmeye yönelik bir yöntem. |
| KR102877920B1 (ko) | 2015-11-16 | 2025-10-30 | 더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 | 티틴-기반 근증 및 다른 티틴성병증의 치료를 위한 물질 및 방법 |
| US11191847B2 (en) | 2016-04-15 | 2021-12-07 | The Trustees Of The University Of Pennsylvania | Gene therapy for treating hemophilia B |
| MX2018012537A (es) * | 2016-04-15 | 2019-02-25 | Univ Pennsylvania | Terapia de genes para tratar hemofilia a. |
| AR114350A1 (es) | 2018-01-31 | 2020-08-26 | Res Institute At Nationwide ChildrenS Hospital | Terapia genética para la distrofia muscular de cinturas del tipo 2c |
| KR20210028162A (ko) | 2018-06-29 | 2021-03-11 | 더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 | 지대근 이영양증 2a형을 치료하기 위한 재조합 아데노 연관 바이러스 생성물 및 방법 |
| US20210348193A1 (en) * | 2018-09-21 | 2021-11-11 | Nightstarx Limited | Compositions and methods for treating retinitis pigmentosa |
| AU2019357039B2 (en) * | 2018-10-12 | 2025-10-09 | Genzyme Corporation | Generation of improved human pah for treatment of severe PKU by liver-directed gene replacement therapy |
| CN112912518A (zh) * | 2018-10-15 | 2021-06-04 | 再生生物股份有限公司 | 用于测量复制缺陷型病毒载体和病毒的感染性的方法 |
| SG11202103917VA (en) | 2018-10-16 | 2021-05-28 | Blueallele Llc | Methods for targeted insertion of dna in genes |
| GB201818816D0 (en) * | 2018-11-19 | 2019-01-02 | Synpromics Ltd | Regulatory nucleic acid sequences |
| TWI851647B (zh) * | 2019-01-16 | 2024-08-11 | 日商武田藥品工業股份有限公司 | 用於a型血友病基因治療之編碼表現增加之重組fviii變異體的病毒載體 |
| AU2020229340A1 (en) * | 2019-02-26 | 2021-09-16 | Research Institute At Nationwide Children's Hospital | Adeno-associated virus vector delivery of B-sarcoglycan and the treatment of muscular dystrophy |
| SG11202109850SA (en) | 2019-03-13 | 2021-10-28 | Generation Bio Co | Non-viral dna vectors and uses thereof for expressing fviii therapeutics |
| RS65421B1 (sr) | 2019-08-21 | 2024-05-31 | Res Inst Nationwide Childrens Hospital | Isporuka adeno-asociranog virusnog vektora alfa-sarkoglikana i lečenje mišićne distrofije |
| CN114929735A (zh) * | 2019-11-01 | 2022-08-19 | 自由行疗法有限公司 | 因子viii构建体 |
| CN111218446B (zh) * | 2019-12-25 | 2023-03-28 | 劲帆生物医药科技（武汉）有限公司 | 一种肝脏特异性启动子及其应用 |
| JP2023510392A (ja) * | 2020-01-16 | 2023-03-13 | 武田薬品工業株式会社 | フェニルケトン尿症に対するアデノ随伴ウイルスベースの遺伝子治療 |
| US20230175014A1 (en) * | 2020-04-27 | 2023-06-08 | The Trustees Of The University Of Pennsylvania | Compositions and methods for reducing nuclease expression and off-target activity using a promoter with low transcriptional activity |
| MX2022014258A (es) | 2020-05-12 | 2023-02-22 | Univ Pennsylvania | Composiciones para la reducción específica de un fármaco de la expresión de transgén. |
| KR20230042513A (ko) * | 2020-07-29 | 2023-03-28 | 프리라인 테라퓨틱스 리미티드 | 폴리펩티드 |
| WO2022165245A1 (en) * | 2021-01-29 | 2022-08-04 | The Trustees Of The University Of Pennsylvania | Compositions and method of use of mutant ace2 decoy variants |
| WO2022165313A1 (en) | 2021-02-01 | 2022-08-04 | Regenxbio Inc. | Gene therapy for neuronal ceroid lipofuscinoses |
| EP4284442A4 (en) * | 2021-02-01 | 2025-04-23 | The Trustees of The University of Pennsylvania | COMPOSITIONS AND METHODS FOR TREATING NIEMANN PICK DISEASE TYPE A |
| EP4219726A1 (en) | 2021-10-15 | 2023-08-02 | Research Institute at Nationwide Children's Hospital | Self-complementary adeno-associated virus vector and its use in treatment of muscular dystrophy |
| EP4428237A4 (en) * | 2021-11-02 | 2026-02-25 | Gritgen Therapeutics Ltd | ISOLATED NUCLEIC ACID MOLECULE AND ITS USES |
| US20250295807A1 (en) | 2021-11-15 | 2025-09-25 | The Trustees Of The University Of Pennsylvania | Compositions for drg-specific reduction of transgene expression |
| WO2023205300A2 (en) * | 2022-04-20 | 2023-10-26 | Asklepios Biopharmaceutical, Inc. | Therapeutic adeno-associated virus using codon optimized nucleic acid encoding factor viii |
| WO2023240222A2 (en) * | 2022-06-10 | 2023-12-14 | University Of Florida Research Foundation, Incorporated | Immune tolerance induction to viral capsids |
| WO2025180508A1 (en) * | 2024-02-29 | 2025-09-04 | Shanghai Vitalgen Biopharma Co., Ltd. | Human factor viii variant expression cassettes and uses thereof for treating hemophilia a |
Family Cites Families (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595886A (en) | 1986-01-27 | 1997-01-21 | Chiron Corporation | Protein complexes having Factor VIII:C activity and production thereof |
| US5661008A (en) | 1991-03-15 | 1997-08-26 | Kabi Pharmacia Ab | Recombinant human factor VIII derivatives |
| US5439824A (en) | 1993-05-06 | 1995-08-08 | The United States Of America | Increased expression of α-1-antitrypsin in expression vectors through the inclusion of intron II |
| US6268212B1 (en) | 1993-10-18 | 2001-07-31 | Amgen Inc. | Tissue specific transgene expression |
| US6818439B1 (en) | 1994-12-30 | 2004-11-16 | Chiron Corporation | Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disorders |
| EP0951544A2 (en) * | 1996-07-03 | 1999-10-27 | Chiron Corporation | Methods for administration of recombinant gene delivery vehicles for treatment of human disease |
| EP1036177A1 (en) | 1997-12-05 | 2000-09-20 | The Immune Response Corporation | Novel vectors and genes exhibiting increased expression |
| US6783961B1 (en) | 1999-02-26 | 2004-08-31 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| US6797505B2 (en) | 1998-05-27 | 2004-09-28 | Cell Genesys, Inc. | Recombinant AAV vectors for gene therapy of hemophilia A |
| US6221349B1 (en) * | 1998-10-20 | 2001-04-24 | Avigen, Inc. | Adeno-associated vectors for expression of factor VIII by target cells |
| US6200560B1 (en) | 1998-10-20 | 2001-03-13 | Avigen, Inc. | Adeno-associated virus vectors for expression of factor VIII by target cells |
| EP1038959A1 (en) | 1999-03-17 | 2000-09-27 | Aventis Behring Gesellschaft mit beschränkter Haftung | Factor VIII without B-domain, comprising one or more insertions of a truncated intron I of factor IX |
| US6610906B1 (en) | 1999-06-09 | 2003-08-26 | The Regents Of The University Of Michigan | Nucleotide sequences for gene regulation and methods of use thereof |
| JP2003511082A (ja) | 1999-10-12 | 2003-03-25 | ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル | 第ｖｉｉｉ因子をコードするアデノ随伴ウィルスベクターとその使用法 |
| ES2284545T3 (es) | 1999-11-16 | 2007-11-16 | Genzyme Corporation | Vectores y transgenes con elementos reguladores para la administracion de genes del higado. |
| EE200200538A (et) | 2000-03-22 | 2004-04-15 | Octagene Gmbh | Rekombinantsete verehüübimisfaktorite produtseerimine inimese rakuliinides |
| US6974667B2 (en) | 2000-06-14 | 2005-12-13 | Gene Logic, Inc. | Gene expression profiles in liver cancer |
| US7351813B2 (en) | 2000-06-20 | 2008-04-01 | The Board Of Trustees Of The Leland Stanford Junior University | Liver-specific gene expression cassettes, and methods of use |
| US6812339B1 (en) | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
| JP2004532822A (ja) | 2001-03-14 | 2004-10-28 | アビジェン， インコーポレイテッド | ビリオンの管逆行感染による組換えアデノ随伴ウイルス媒介遺伝子移入 |
| US8021875B2 (en) | 2001-08-27 | 2011-09-20 | Roche Madison Inc. | Methods for expression of transgenes |
| ES2319745T3 (es) | 2001-10-05 | 2009-05-12 | Expression Therapeutics, Llc | Secuencias de acidos nucleicos y aminoacidos que codifican polipeptidos de factor viii de alto nivel de expresion, y metodos de uso. |
| MX359371B (es) | 2001-11-13 | 2018-09-25 | Univ Pennsylvania | Un metodo para detectar y/o identificar secuencias del virus adeno-asociado y aislamiento de secuencias novedosas identificadas de ese modo. |
| PT1453547T (pt) | 2001-12-17 | 2016-12-28 | Univ Pennsylvania | Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas |
| US8005620B2 (en) | 2003-08-01 | 2011-08-23 | Dna Twopointo Inc. | Systems and methods for biopolymer engineering |
| EP2434420A3 (en) | 2003-08-01 | 2012-07-25 | Dna Twopointo Inc. | Systems and methods for biopolymer engineering |
| EP2345731B1 (en) | 2003-09-30 | 2015-10-21 | The Trustees of the University of Pennsylvania | Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof |
| DE602004018349D1 (de) | 2003-10-16 | 2009-01-22 | Claude Negrier | MODIFIZIERTE cDNA FÜR HOHE EXPRESSIONSNIVEAUS VON FAKTOR VIII UND DESSEN DERIVATEN |
| CA2547569C (en) | 2003-12-03 | 2013-04-16 | University Of Rochester | Recombinant factor viii having increased specific activity |
| WO2006036502A2 (en) | 2004-09-22 | 2006-04-06 | St. Jude Children's Research Hospital | Improved expression of factor ix in gene therapy vectors |
| US8008468B2 (en) | 2005-02-16 | 2011-08-30 | Benitec, Inc. | RNAi expression constructs with liver-specific enhancer/promoter |
| WO2006102072A2 (en) | 2005-03-23 | 2006-09-28 | The Trustees Of The University Of Pennsylvania | Use of a pa131 polypeptide in treatment of atherosclerosis |
| KR20080007226A (ko) | 2005-04-14 | 2008-01-17 | 체에스엘 베링 게엠베하 | 증가된 안정성을 가진 변형된 응고 인자 ⅷ 및 이의 유도체 |
| WO2007016331A2 (en) | 2005-07-29 | 2007-02-08 | Children's Hospital Medical Center | Classification and diagnosis of the molecular basis of cholestasis |
| US7943374B2 (en) | 2005-08-21 | 2011-05-17 | Markus Hildinger | Super-size adeno-associated viral vector harboring a recombinant genome larger than 5.7 kb |
| JP2009519710A (ja) | 2005-12-16 | 2009-05-21 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 遺伝子発現調節エレメントのハイスループットでの特徴付けのための機能性アレイ |
| WO2008016391A2 (en) | 2006-01-31 | 2008-02-07 | The Board Of Trustees Of The Leland Stanford Junior University | Self-complementary parvoviral vectors, and methods for making and using the same |
| WO2007120533A2 (en) * | 2006-03-30 | 2007-10-25 | The Board Of Trustees Of The Leland Stanford Junior University | Minigene expression cassette |
| ES2535877T3 (es) | 2006-06-19 | 2015-05-18 | Asklepios Biopharmaceutical, Inc. | Genes de Factor VIII y Factor IX modificados y vectores para la terapia génica |
| WO2008073303A2 (en) | 2006-12-07 | 2008-06-19 | Switchgear Genomics | Transcriptional regulatory elements of biological pathways, tools, and methods |
| CA2673459C (en) | 2006-12-22 | 2016-09-13 | Stefan Schulte | Modified coagulation factors with prolonged in vivo half-life |
| WO2008118258A2 (en) | 2007-02-06 | 2008-10-02 | Genizon Biosciences Inc. | Genemap of the human genes associated with adhd |
| KR101235560B1 (ko) | 2008-02-14 | 2013-02-25 | 재단법인 목암생명공학연구소 | 유전자 치료용 코딩 서열의 발현에 적합한 발현 벡터 |
| KR100981092B1 (ko) | 2008-02-29 | 2010-09-08 | 고려대학교 산학협력단 | 제8 혈액응고 인자와 폰 빌리 블란트 인자 변이체의 재조합발현 벡터 시스템 |
| EP2271763A2 (en) | 2008-04-03 | 2011-01-12 | Yeda Research And Development Company Ltd. | Methods of expressing a polypeptide in the brain and nucleic acid constructs capable of same |
| CA2722238C (en) | 2008-04-22 | 2017-11-28 | Life Sciences Research Partners Vzw | Liver-specific nucleic acid regulatory elements and methods and use thereof |
| US20110306512A1 (en) | 2008-06-25 | 2011-12-15 | Dxterity Diagnostics | Gene Expression Profiling for Identification, Monitoring, and Treatment of Osteoarthritis |
| KR101034811B1 (ko) | 2008-08-25 | 2011-05-16 | 단국대학교 산학협력단 | 조직 특이적 프로모터와 암 특이 유전자를 타겟팅하는트랜스-스플라이싱 라이보자임을 포함하는 재조합아데노바이러스 및 이의 용도 |
| US20120093775A1 (en) | 2009-03-27 | 2012-04-19 | Proyecto De Biomedicina Cima, S.L. | Methods and compositions for the treatment of cirrhosis and liver fibrosis |
| CN101935674A (zh) * | 2009-06-30 | 2011-01-05 | 中国医学科学院血液学研究所 | 一种用于血友病b基因治疗的腺病毒载体及其用途 |
| GB0911870D0 (en) | 2009-07-08 | 2009-08-19 | Ucl Business Plc | Optimised coding sequence and promoter |
| WO2011109380A1 (en) | 2010-03-01 | 2011-09-09 | The Children's Hospital Of Philadelphia | Nucleic acids for targeting multiple regions of the hcv genome |
| WO2011126808A2 (en) | 2010-03-29 | 2011-10-13 | The Trustees Of The University Of Pennsylvania | Pharmacologically induced transgene ablation system |
| US9315825B2 (en) * | 2010-03-29 | 2016-04-19 | The Trustees Of The University Of Pennsylvania | Pharmacologically induced transgene ablation system |
| EP2394667A1 (en) | 2010-06-10 | 2011-12-14 | Laboratorios Del Dr. Esteve, S.A. | Vectors and sequences for the treatment of diseases |
| SI2480678T1 (sl) | 2010-09-02 | 2014-06-30 | Molmed Spa | Stabilno proizvajanje lentivirusnih vektorjev |
| FR2977562B1 (fr) | 2011-07-06 | 2016-12-23 | Gaztransport Et Technigaz | Cuve etanche et thermiquement isolante integree dans une structure porteuse |
| AU2013336601B2 (en) * | 2012-10-26 | 2018-01-25 | Vrije Universiteit Brussel | Vector for liver-directed gene therapy of hemophilia and methods and use thereof |
| US10398787B2 (en) * | 2012-10-26 | 2019-09-03 | Vrije Universiteit Brussel | Vectors for liver-directed gene therapy of hemophilia and methods and use thereof |
| WO2015012924A2 (en) | 2013-04-29 | 2015-01-29 | The Trustees Of The University Of Pennsylvania | Tissue preferential codon modified expression cassettes, vectors containing same, and use thereof |
| EP3044231B1 (en) * | 2013-09-12 | 2020-08-05 | BioMarin Pharmaceutical Inc. | Aav vectors comprising a gene encoding factor viii |
| MX388739B (es) * | 2015-02-06 | 2025-03-20 | Univ North Carolina Chapel Hill | Casetes optimizados de expresión del gen humano del factor viii de coagulación y su uso. |
| EP3288594B1 (en) * | 2015-04-27 | 2022-06-29 | The Trustees of The University of Pennsylvania | Dual aav vector system for crispr/cas9 mediated correction of human disease |
| EA202190827A1 (ru) * | 2015-11-13 | 2021-11-30 | Баксалта Инкорпорейтед | Вирусные векторы, кодирующие рекомбинантные варианты fviii с повышенной экспрессией для генной терапии гемофилии a |
| US11028372B2 (en) | 2015-12-11 | 2021-06-08 | The Trustees Of The University Of Pennsylvania | Scalable purification method for AAVRH10 |
| MX2018012537A (es) * | 2016-04-15 | 2019-02-25 | Univ Pennsylvania | Terapia de genes para tratar hemofilia a. |
-
2017
- 2017-04-13 MX MX2018012537A patent/MX2018012537A/es unknown
- 2017-04-13 KR KR1020187032617A patent/KR102450833B1/ko active Active
- 2017-04-13 EP EP17734159.1A patent/EP3452102B9/en active Active
- 2017-04-13 CA CA3019425A patent/CA3019425A1/en active Pending
- 2017-04-13 PE PE2018001994A patent/PE20181922A1/es unknown
- 2017-04-13 AU AU2017248659A patent/AU2017248659B2/en not_active Ceased
- 2017-04-13 WO PCT/US2017/027396 patent/WO2017180857A1/en not_active Ceased
- 2017-04-13 RU RU2018136611A patent/RU2762257C2/ru active
- 2017-04-13 SG SG10202009849WA patent/SG10202009849WA/en unknown
- 2017-04-13 SG SG11201808422QA patent/SG11201808422QA/en unknown
- 2017-04-13 US US16/093,798 patent/US11779656B2/en active Active
- 2017-04-13 BR BR112018071200-0A patent/BR112018071200A2/pt not_active Application Discontinuation
- 2017-04-13 CN CN201780023787.5A patent/CN109562191A/zh active Pending
- 2017-04-13 JP JP2018554331A patent/JP7347933B2/ja active Active
- 2017-04-13 PE PE2023002954A patent/PE20250736A1/es unknown
- 2017-04-13 TW TW106112302A patent/TWI791433B/zh not_active IP Right Cessation
-
2018
- 2018-09-28 ZA ZA2018/06477A patent/ZA201806477B/en unknown
- 2018-10-08 IL IL262215A patent/IL262215B2/en unknown
- 2018-10-14 SA SA518400233A patent/SA518400233B1/ar unknown
-
2019
- 2019-11-22 US US16/691,822 patent/US10888628B2/en active Active
-
2022
- 2022-01-27 JP JP2022011052A patent/JP2022062121A/ja active Pending
-
2023
- 2023-08-08 US US18/446,243 patent/US20240000974A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019513794A5 (https=) | ||
| RU2018136611A (ru) | Генная терапия для лечения гемофилии a | |
| JP2020514286A5 (https=) | ||
| JP2020510428A5 (https=) | ||
| JP2018537984A5 (https=) | ||
| JP2019089787A5 (https=) | ||
| JP2018520997A5 (https=) | ||
| JP2017512466A5 (https=) | ||
| JP2022500066A5 (https=) | ||
| ES2640586T3 (es) | Secuencias del factor VIII | |
| JP2024054426A5 (https=) | ||
| JP2020519292A5 (https=) | ||
| FI3684423T3 (fi) | Adenoassesioidun viruksen kapsidivariantteja ja niiden käyttömenetelmiä | |
| JP2019503649A5 (https=) | ||
| FI4206216T3 (fi) | Adenoassosioituneen viruksen kapsidimuunnoksia ja menetelmiä niiden käyttämiseksi | |
| JP2014012022A5 (https=) | ||
| JP2019513779A5 (https=) | ||
| HRP20230522T1 (hr) | Isporuka adeno-povezanog virusnog vektora mišićno specifičnog mikrodistrofina za liječenje mišićne distrofije | |
| TW201629225A (zh) | 第九因子基因療法 | |
| JP2014512171A5 (https=) | ||
| JP2018531609A5 (https=) | ||
| JP2016512683A5 (https=) | ||
| HRP20250897T1 (hr) | Genska terapija za neurodegenerativne poremećaje | |
| JP2015521465A5 (https=) | ||
| JP2020522269A5 (https=) |